LP-187 Deucravacitinib, an oral, allosteric, tyrosine kinase 2 (TYK2) inhibitor, in patients with active systemic lupus erythematosus: patient-reported outcomes in a phase 2 trial
M. Mosca, L. Arnaud, A. Askanase, C. Hobar, S. Singhal, Subhashish Banerjee, S. Pomponi, Jiyoon C. Choi, Adrian Coles, B. Becker, V. Strand
{"title":"LP-187 Deucravacitinib, an oral, allosteric, tyrosine kinase 2 (TYK2) inhibitor, in patients with active systemic lupus erythematosus: patient-reported outcomes in a phase 2 trial","authors":"M. Mosca, L. Arnaud, A. Askanase, C. Hobar, S. Singhal, Subhashish Banerjee, S. Pomponi, Jiyoon C. Choi, Adrian Coles, B. Becker, V. Strand","doi":"10.1136/lupus-2023-kcr.262","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":359413,"journal":{"name":"E-Poster Presentation","volume":"28 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"E-Poster Presentation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/lupus-2023-kcr.262","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
